Results 311 to 320 of about 2,974,682 (398)
Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes. [PDF]
Pande A +4 more
europepmc +1 more source
Abstract Background Erectile dysfunction in people living with HIV is a multifactorial disease, but the role of penile vascular status assessed by dynamic penile color Doppler echography is underexplored. Objectives This study assessed penile vascular status in young males living with HIV experiencing erectile dysfunction, comparing them to HIV ...
Giorgio Tiecco +9 more
wiley +1 more source
Abstract Background Low‐intensity shockwave therapy (LiST) is a first‐line treatment for vasculogenic erectile dysfunction (ED). However, its efficacy in challenging cases, such as ED solely due to type 2 diabetes mellitus (DM) or coronary artery disease (CAD), has not been adequately assessed.
Nikolaos Pyrgidis +3 more
wiley +1 more source
Neuroprotective Effects of Phosphodiesterase Inhibitors on Sestrin-2 (SESN2) Expression and Autophagy in Alzheimer's Disease Model. [PDF]
Faikoglu G +7 more
europepmc +1 more source
Successful treatment of lichen spinulosis with topical roflumilast: A case report. [PDF]
He R, Xu Y, Naert K, Chia JC.
europepmc +1 more source
Plasmodium falciparum gametogenesis essential protein 1 (GEP1) is a transmission-blocking target. [PDF]
Huppertz F +5 more
europepmc +1 more source
The impact of PDE5 inhibitors on cardiovascular outcomes. [PDF]
Ghantous I +9 more
europepmc +1 more source

